TranSenda and Harvard Clinical Research Institute Announce Office-Smart Deployment
News Jun 22, 2009
TranSenda International, LLC, announced the deployment of a clinical trial software solution for Harvard Clinical Research Institute (HCRI) that expands the products and services already under contract between the two parties.
HCRI was seeking to continue the process of simplifying its existing systems to manage and monitor various spreadsheets, information and documents related to their clinical trials. To accomplish this, HCRI has migrated from initially using TranSenda’s Clinical Trial Manager product to Office-Smart Clinical Trial Manager™ and Office-Smart Clinical Payment Manager™.
This subsequent deployment also included the purchase of ClinBUS Connector™ along with professional services to consolidate existing data sets into a single repository for clinical trial management and related operational data.
By adding Office-Smart solutions to its organization, HCRI can now take advantage of advanced capabilities that allow integration between Clinical Trial Manager and the Microsoft® Office System. Office-Smart solutions also use TranSenda’s innovative ClinBUS® data interchange technology to make data available through Microsoft SharePoint Server.
Among other advantages, ClinBUS enables the use of SharePoint data grids to connect Microsoft Excel spreadsheets and databases, including Microsoft Access, to Office-Smart solutions for data import or integration. With this new level of connectivity, HCRI can now use data for the creation of SharePoint websites and dashboards; and to make better use of their existing Microsoft Office tools, including Excel, Access, Outlook and Word.
In addition to consolidating Microsoft Excel spreadsheet data, HCRI will also be integrating Office-Smart Clinical Trial Manager with a number of Clinical Trial Data Management Systems, including Electronic Data Capture (EDC) system(s) as well as their web-based learning management system.
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
Bumblebee Threats Tested in 'Virtual Safe Space'News
The many threats facing bumblebees can be tested using a “virtual safe space” created by scientists at the University of Exeter. Bumble-BEEHAVE provides a computer simulation of how colonies will develop and react to multiple factors including pesticides, parasites and habitat loss.READ MORE
XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery ServicesNews
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.READ MORE